Antibiotic Exposure Positively Linked to IBD Development
TUESDAY, Jan. 10, 2023 (HealthDay News) — There is a positive correlation between antibiotic exposure and development of inflammatory bowel disease (IBD), especially among adults aged 40 years and older, according to a study published online Jan. 9 i…
Learn MoreWaning Immunity Most Consistent With Recent Mumps Outbreaks
TUESDAY, Jan. 10, 2023 (HealthDay News) — A waning immunity model is most consistent with recently observed resurgent outbreaks of mumps in countries with high vaccine coverage, according to a study published online Jan. 9 in the Proceedings of the N…
Learn MoreUna vacuna contra la malaria de 3 dosis se muestra promisoria en un ensayo africano
VIERNES, 6 de enero de 2023 (HealthDay News) — Una nueva investigación ha confirmado que una vacuna contra la malaria de tres dosis es tanto segura como efectiva en adultos de África Occidental, incluso los que se habían expuesto antes a la malaria.L…
Learn MoreFree Spike Antigen ID’d in Post-SARS-CoV-2 mRNA Vaccine Myocarditis
MONDAY, Jan. 9, 2023 (HealthDay News) — Individuals who develop myocarditis following a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccine have no difference in vaccine-induced immune responses compared with asymptomatic vaccin…
Learn MoreDelay in Time to Antibiotics Permissible for Inpatient Neutropenic Fever
MONDAY, Jan. 9, 2023 (HealthDay News) — For patients with hematologic malignancy who develop inpatient neutropenic fever, delays in time to antibiotics do not significantly affect overall survival at 180 days, according to a study published in the Ja…
Learn MoreMIS-C Seems More Common, Severe Than Previously Thought
FRIDAY, Jan. 6, 2023 (HealthDay News) — Multisystem inflammatory syndrome in children (MIS-C) seems to be more common and more severe than previously thought, according to a study published online Jan. 5 in JAMA Network Open.William Encinosa, Ph.D., …
Learn MoreVV116 Noninferior to Nirmatrelvir-Ritonavir for COVID-19
FRIDAY, Jan. 6, 2023 (HealthDay News) — VV116 is noninferior to nirmatrelvir-ritonavir with respect to time to sustained clinical recovery for adults with mild-to-moderate COVID-19 at risk for progression, according to a study published online Dec. 2…
Learn More3-Dose Malaria Vaccine Shows Promise in African Trial
FRIDAY, Jan. 6, 2023 (HealthDay News) – New research has confirmed that a three-dose malaria vaccine is both safe and effective in West African adults, including those previously exposed to malaria.Researchers at the University of Maryland Center for …
Learn MoreRacial/Ethnic Variation Seen in COVID-19 Vaccination Status in Children
THURSDAY, Jan. 5, 2023 (HealthDay News) — Racial/ethnic disparities are seen in COVID-19 vaccination coverage among children and adolescents, according to research published in the Jan. 6 issue of the U.S. Centers for Disease Control and Prevention …
Learn More